Remove 2022 Remove Communication Remove Generic Medicine
article thumbnail

Pathbreakers: The journey of first generics

Pharmaceutical Technology

In recent years, first generics have improved patient access to essential treatments and offered affordable treatment options for patients with multiple sclerosis, asthma, heart disease, diabetes, and even the flu. However, that percentage of multiple first generics is not very high—approximately 10.6% from 2001 to 2022.”

FDA 98
article thumbnail

Medicine and medical device shortages: what’s been done and what’s to do

Hospital Pharmacy Europe

In 2022, the Executive Steering Group on Shortages and Safety of Medicinal Products was established to ensure a robust response to medicine supply issues caused by major events or public health emergencies. The paper calls for a European-wide investigation to define the causes and improve communication between stakeholders.

article thumbnail

What a mild recession could mean for small biotechs in 2023

Pharmaceutical Technology

in 2022 to 1% in 2023 due to the “tightening of monetary and financial conditions”. Koerber-Walker discussed how the Inflation Reduction Act, introduced in 2022 , may benefit biologics companies’ funding plans going into the next year. Certain companies will struggle more than others with accruing investment from venture capital firms.